3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2/3
2
Phase 2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Paresthesia
2
Hypesthesia
2
Depression
2
Anxiety Disorders
2
Interventions
Cisplatin
22
pembrolizumab
17
Drug Therapy
16
Carboplatin
15
Paclitaxel
12
Dexamethasone
12
Gemcitabine
11
Magnetic Resonance Spectroscopy
10
Bevacizumab
10
Docetaxel
9
venetoclax
8
atezolizumab
8
Pemetrexed
8
Oxaliplatin
8
Specimen Handling
7
Radiotherapy
7
Nivolumab
7
Cyclophosphamide
7
Capecitabine
7
Methotrexate
6
130-nm albumin-bound paclitaxel
6
durvalumab
5
blinatumomab
5
Cytarabine
5
Androgen Antagonists
5
tislelizumab
4
spartalizumab
4
pertuzumab
4
Vincristine
4
Trimethoprim, Sulfamethoxazole Drug Combination
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Recruiting
×
Oxygen
×
Clear all
NCT06799351
2025-02-12
OzoParQTmicrob
Dr. Negrin University Hospital
Phase 2/3
Recruiting
42 enrolled
NCT06706544
2025-02-11
OzoParQT
Dr. Negrin University Hospital
Phase 2/3
Recruiting
42 enrolled